Back
Fidelity Disruptive Medicine ETF Vs. Axon Enterprise, Inc. Industry Stock Comparison
Sell
48
FMED
Fidelity Disruptive Medicine ETF
Last Price:
$24.32
Seasonality Move:
-2.62%
Sell
8
AXON
Axon Enterprise, Inc.
Last Price:
$412.75
Seasonality Move:
13.82%
Sell
48
Fidelity Disruptive Medicine ETF (FMED)
is a Sell
Is Fidelity Disruptive Medicine ETF a Buy, Sell or Hold?
-
The current Fidelity Disruptive Medicine ETF [FMED] share price is $24.67. The Score for FMED is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
FMED is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
8
Axon Enterprise, Inc. (AXON)
is a Sell
Is Axon Enterprise, Inc. a Buy, Sell or Hold?
-
The current Axon Enterprise, Inc. [AXON] share price is $412.81. The Score for AXON is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
-
AXON is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
FMED Stock Price Chart
What is Fidelity Disruptive Medicine ETF's stock price today?
-
The Fidelity Disruptive Medicine ETF share price today is $24.67Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FMED is experiencing buying pressure, which is a positive indicator for future bullish movement.
AXON Stock Price Chart
What is Axon Enterprise, Inc.'s stock price today?
-
The Axon Enterprise, Inc. share price today is $412.81Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AXON is experiencing slight selling pressure.
FMED Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.37 | Sell |
| Relative Strength Index (14 RSI): | 48.65 | Sell |
| Chaikin Money Flow: | 14909 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24 - 25.46) | Sell |
| Bollinger Bands (100): | (25.21 - 27.91) | Sell |
AXON Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -24.88 | Sell |
| Relative Strength Index (14 RSI): | 31.44 | Sell |
| Chaikin Money Flow: | -1094 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (446.56 - 552.94) | Sell |
| Bollinger Bands (100): | (466.17 - 597.49) | Sell |
FMED Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.22 | Buy |
| 20-day SMA: | 24.46 | Buy |
| 50-day SMA: | 25.56 | Sell |
| 200-day SMA: | 25.59 | Sell |
| 8-day EMA: | 24.36 | Buy |
| 20-day EMA: | 24.58 | Buy |
| 50-day EMA: | 25.33 | Sell |
| 200-day EMA: | 25.67 | Sell |
AXON Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 434.16 | Sell |
| 20-day SMA: | 482.99 | Sell |
| 50-day SMA: | 489.64 | Sell |
| 200-day SMA: | 639.76 | Sell |
| 8-day EMA: | 436.92 | Sell |
| 20-day EMA: | 466.67 | Sell |
| 50-day EMA: | 498.4 | Sell |
| 200-day EMA: | 578.97 | Sell |
Fidelity Disruptive Medicine ETF Earnings Growth & FMED Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Axon Enterprise, Inc. Earnings Growth & AXON Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.15 per share, an increase this year of $1.47 per share, and an increase next year of $2.78 per share.
Fidelity Disruptive Medicine ETF Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Axon Enterprise, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||